Earli

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

Cell Design Labs

This biotherapeutics company develops programmable cell therapies for cancer patients by engineering immune cells with synthetic genetic circuits to improve precision and safety.

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.

Constructive Bio

This company engineers synthetic genomes and programmable cells to produce novel proteins and biomaterials for pharmaceutical, agricultural and manufacturing partners.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

Bioarchitech

This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.